HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D J Drucker Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

3/2010The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D J Drucker Research Topics

Disease

5Type 2 Diabetes Mellitus (MODY)
11/2011 - 09/2001
3Inflammation (Inflammations)
12/2019 - 04/2001
3Body Weight (Weight, Body)
11/2000 - 07/2000
2Obesity
12/2019 - 11/2011
2Weight Gain
01/2006 - 09/2000
2Intestinal Diseases (Diseases, Intestinal)
02/2001 - 06/2000
2Weight Loss (Weight Reduction)
01/2001 - 06/2000
1Neurodegenerative Diseases (Neurodegenerative Disease)
12/2019
1Psoriasis (Pustulosis Palmaris et Plantaris)
11/2011
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2010
1Cardiovascular Diseases (Cardiovascular Disease)
03/2010
1Carcinoma (Carcinomatosis)
02/2005
1Diabetes Mellitus
09/2001
1Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature
04/2001
1Sepsis (Septicemia)
04/2001
1Bacteremia
01/2001
1Mucositis
01/2001
1Neoplasms (Cancer)
01/2001
1Insulin Resistance
09/2000
1AIDS-Related Complex (ARC)
07/2000
1Bacterial Infections (Bacterial Infection)
06/2000
1Atrophy
06/2000
1Enteritis
06/2000
1Colitis
06/2000
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2000

Drug/Important Bio-Agent (IBA)

7Glucagon-Like Peptide 1 (GLP 1)IBA
12/2019 - 09/2000
2Glucagon-Like Peptide-1 Receptor AgonistsIBA
12/2019 - 11/2011
2Glucagon-Like Peptide-1 ReceptorIBA
11/2011 - 04/2010
2Glucose (Dextrose)FDA LinkGeneric
04/2010 - 01/2006
2Glucagon (Glukagon)FDA Link
01/2006 - 04/2000
2Exenatide (Byetta)FDA Link
01/2006 - 11/2000
2Messenger RNA (mRNA)IBA
02/2005 - 07/2000
2Peptides (Polypeptides)IBA
04/2001 - 02/2001
2LeptinIBA
09/2000 - 07/2000
1Neuroprotective AgentsIBA
12/2019
1Hormones (Hormone)IBA
12/2019
1IncretinsIBA
11/2011
1Insulin (Novolin)FDA Link
11/2011
1Metformin (Glucophage)FDA LinkGeneric
02/2011
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
01/2006
1Antisense OligonucleotidesIBA
01/2006
1Glucagon Receptors (Glucagon Receptor)IBA
01/2006
1Blood Glucose (Blood Sugar)IBA
09/2001
1Phosphotransferases (Kinase)IBA
04/2001
1CytokinesIBA
04/2001
1AntimetabolitesIBA
01/2001
1Topoisomerase I InhibitorsIBA
01/2001
1Irinotecan (Camptosar)FDA LinkGeneric
01/2001
1Fluorouracil (Carac)FDA LinkGeneric
01/2001
1Glucagon-Like Peptides (Enteroglucagon)IBA
09/2000
1Cocaine (Cocaine HCl)IBA
07/2000
1Dynorphins (Dynorphin)IBA
07/2000
1Dimenhydrinate (DMH)FDA LinkGeneric
07/2000
1NeurotensinIBA
07/2000
1Amphetamine (Amfetamine)FDA LinkGeneric
07/2000
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
06/2000
1Indomethacin (Indometacin)FDA LinkGeneric
06/2000
1AminopeptidasesIBA
06/2000

Therapy/Procedure

2Drug Therapy (Chemotherapy)
12/2019 - 01/2001
1Therapeutics
11/2011
1Parenteral Nutrition
06/2000